{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:49:03Z","timestamp":1793620143602,"version":"4.5.0"},"reference-count":147,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Type 2 diabetes mellitus (T2DM) is a metabolically heterogeneous disease for which current approaches to early diagnosis and risk stratification remain limited. Circular RNAs (circRNAs) have emerged as promising molecular candidates because of their stability, disease relevance, and regulatory versatility. Circular RNAs (circRNAs) have emerged as a promising class of non-coding RNAs that exhibit unique advantages, such as high stability, disease specificity, and the ability to act as regulators in competing endogenous RNA (ceRNA) networks. This review summarizes the current understanding of circRNAs in T2DM, highlighting their potential as diagnostic biomarkers and their roles in metabolic dysfunction. We explore how circRNAs contribute to key pathogenic processes in T2DM, including insulin resistance, glucose uptake, \u03b2-cell survival, inflammation, and vascular dysfunction. Additionally, we discuss the challenges in circRNA research, including technical biases, cohort heterogeneity, and the need for rigorous mechanistic validation. The review concludes by outlining future directions for circRNA-based research, including multicenter prospective studies, single-cell and spatial transcriptomic integration, and the development of circRNA-based companion diagnostics for precision medicine in T2DM.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1815722","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:26:44Z","timestamp":1778819204000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Circular RNAs as diagnostic biomarkers in type 2 diabetes mellitus: implications in metabolic dysfunction and immune-inflammatory crosstalk"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhaoxia","family":"Liu","sequence":"first","affiliation":[{"name":"General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[{"name":"General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoshuang","family":"Pu","sequence":"additional","affiliation":[{"name":"General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiongtao","family":"Yang","sequence":"additional","affiliation":[{"name":"General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Li","sequence":"additional","affiliation":[{"name":"General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shipin","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pediatric Nephrology, Chengdu Women\u2019s and Children\u2019s Central Hospital, School of Medicine, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"General Medicine, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China","place":["Chengdu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224611","article-title":"Type 2 diabetes mellitus and cognitive impairment","volume":"53","author":"Damanik","year":"2021","journal-title":"Acta Med Indones"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00394-019-02147-6","article-title":"Improving type 2 diabetes mellitus glycaemic control through lifestyle modification implementing diet intervention: a systematic review and meta-analysis","volume":"59","author":"Garc\u00eda-Molina","year":"2020","journal-title":"Eur J Nutr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.158","article-title":"Resistance to type 2 diabetes mellitus: a matter of hormesis","volume":"8","author":"Kolb","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4314\/njm.v15i3.37212","article-title":"Type 2 diabetes mellitus: a review of pharmacological treatment","volume":"15","author":"Siminialayi","year":"2006","journal-title":"Niger J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/17446651.2024.2320631","article-title":"Current usage of long-acting insulin analogs in patients with type 2 diabetes mellitus","volume":"19","author":"Aktas","year":"2024","journal-title":"Expert Rev Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1366368","article-title":"Current barriers to initiating insulin therapy in individuals with type 2 diabetes","volume":"15","author":"Gald\u00f3n Sanz-Pastor","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","doi-asserted-by":"publisher","first-page":"299","DOI":"10.2165\/00044011-200727050-00002","article-title":"Biphasic insulin aspart in type 2 diabetes mellitus: an evidence-based medicine review","volume":"27","author":"Gough","year":"2007","journal-title":"Clin Drug Investig"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15259","article-title":"Efficacy and safety of once-weekly versus once-daily basal insulin analogues in the treatment of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"25","author":"Karakasis","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-025-09960-x","article-title":"Insulin icodec: a novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus","volume":"26","author":"Pham","year":"2025","journal-title":"Rev Endocr Metab Disord"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.03.023","article-title":"Initiating and intensifying insulin therapy in type 2 diabetes mellitus","volume":"121","author":"Tibaldi","year":"2008","journal-title":"Am J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12143","article-title":"Type 2 diabetes mellitus-related genetic polymorphisms in microRNAs and microRNA target sites","volume":"6","author":"Gong","year":"2014","journal-title":"J Diabetes"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2301029","article-title":"MicroRNAs in type 2 diabetes mellitus: potential role of physical exercise","volume":"23","author":"Improta-Caria","year":"2022","journal-title":"Rev Cardiovasc Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1615\/critrevimmunol.2022044927","article-title":"Diagnostic and therapeutic application of exosomal microRNAs inducing inflammation in type 2 diabetes mellitus","volume":"42","author":"Preethi","year":"2022","journal-title":"Crit Rev Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1080\/13813455.2020.1843498","article-title":"Non-coding RNAs and type 2 diabetes mellitus","volume":"129","author":"Taheri","year":"2023","journal-title":"Arch Physiol Biochem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417406","article-title":"Plasma microRNA profiling in type 2 diabetes mellitus: a pilot study","volume":"24","author":"Tonyan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3390\/biom14111364","article-title":"Emerging roles of ncRNAs in type 2 diabetes mellitus: from mechanisms to drug discovery","volume":"14","author":"Yang","year":"2024","journal-title":"Biomolecules"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.52575","article-title":"has_circ_0071106 can be used as a diagnostic marker for type 2 diabetes","volume":"18","author":"Yingying","year":"2021","journal-title":"Int J Med Sci"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23439","article-title":"has_circ_CCNB1 and has_circ_0009024 function as potential biomarkers for the diagnosis of type 2 diabetes mellitus","volume":"34","author":"Chen","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.790591","article-title":"hsa_circ_0111707 is associated with risk of stress-related type 2 diabetes via sponging miR-144-3p","volume":"12","author":"Yan","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158129","article-title":"Identification of novel insulin resistance related ceRNA network in T2DM and its potential editing by CRISPR\/Cas9","volume":"22","author":"Matboli","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1186\/s12967-025-07007-y","article-title":"The circRNA-mediated ceRNA molecular regulatory network in fatigue-type type 2 diabete","volume":"23","author":"Zhen","year":"2025","journal-title":"J Transl Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1405726","article-title":"Exploring the pathogenesis, biomarkers, and potential drugs for type 2 diabetes mellitus and acute pancreatitis through a comprehensive bioinformatic analysis","volume":"15","author":"Zhong","year":"2024","journal-title":"Front Endocrinol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.gene.2019.04.076","article-title":"Association of TATA box-binding protein-associated factor RNA polymerase I subunit C (TAF1C) with T2DM","volume":"706","author":"Abdulwahab","year":"2019","journal-title":"Gene"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139519","article-title":"Micro-RNA binding site polymorphisms in the WFS1 gene are risk factors of diabetes mellitus","volume":"10","author":"Elek","year":"2015","journal-title":"PloS One"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13639","article-title":"m(6) A mRNA methylation: biological features, mechanisms, and therapeutic potentials in type 2 diabetes mellitus","volume":"24","author":"Ren","year":"2023","journal-title":"Obes Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.630032","article-title":"Non-coding RNA as biomarkers for type 2 diabetes development and clinical management","volume":"12","author":"Chi","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12920-023-01476-0","article-title":"Diagnostic accuracy of circular RNA for diabetes mellitus: a systematic review and diagnostic meta-analysis","volume":"16","author":"Dehghanbanadaki","year":"2023","journal-title":"BMC Med Genomics"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-019-04937-x","article-title":"Circular RNAs in \u03b2-cell function and type 2 diabetes-related complications: a potential diagnostic and therapeutic approach","volume":"46","author":"Ghasemi","year":"2019","journal-title":"Mol Biol Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s12864-024-10290-6","article-title":"Identification of circRNAs expression profiles and functional networks in parotid gland of type 2 diabetes mouse","volume":"25","author":"Huang","year":"2024","journal-title":"BMC Genomics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/3720602","article-title":"Identification of potentially functional circular RNA\/long noncoding RNA-microRNA-mRNA regulatory networks associated with vascular injury in type 2 diabetes mellitus by integrated microarray analysis","volume":"2023","author":"Leng","year":"2023","journal-title":"J Diabetes Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1089\/gtmb.2021.0205","article-title":"The differential expression of circular RNAs in type 2 diabetes mellitus and latent autoimmune diabetes in adults","volume":"26","author":"Ning","year":"2022","journal-title":"Genet Test Mol Biomarkers"},{"key":"B32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1152\/physiolgenomics.00105.2021","article-title":"Integrated analysis of transcriptome profiling of lncRNAs and mRNAs in livers of type 2 diabetes mellitus","volume":"54","author":"Lan","year":"2022","journal-title":"Physiol Genomics"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13224","article-title":"Construction of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in type 2 diabetes mellitus","volume":"21","author":"Lin","year":"2017","journal-title":"J Cell Mol Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.915017","article-title":"Exploration of shared TF-miRNA\u2013mRNA and mRNA-RBP-pseudogene networks in type 2 diabetes mellitus and breast cancer","volume":"13","author":"Tong","year":"2022","journal-title":"Front Immunol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40708-025-00277-8","article-title":"Regulation of tau protein by circCwc27: shared pathogenic mechanisms in type 2 diabetes mellitus and Alzheimer's disease","volume":"12","author":"Fang","year":"2025","journal-title":"Brain Inform"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.22541\/au.170663562.20926294\/v1","article-title":"Identification of ferroptosis-related genes in type 2 diabetes mellitus based on machine learning","volume":"11","author":"Wang","year":"2023","journal-title":"Immun Inflammation Dis"},{"key":"B37","doi-asserted-by":"publisher","first-page":"19807","DOI":"10.1038\/s41598-023-47189-3","article-title":"Circ_0004535\/miR-1827\/CASP8 network involved in type 2 diabetes mellitus with nonalcoholic fatty liver disease","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202406.1968.v1","article-title":"Translation of circular RNAs","volume":"53","author":"Margvelani","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1002\/jnr.24356","article-title":"The interaction of circRNAs and RNA binding proteins: an important part of circRNA maintenance and function","volume":"98","author":"Zang","year":"2020","journal-title":"J Neurosci Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07060-5","article-title":"Nuclear export of circular RNA","volume":"627","author":"Ngo","year":"2024","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12429","article-title":"Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans","volume":"7","author":"Holdt","year":"2016","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.2174\/0118715303320146240816113924","article-title":"M6a methylation: a new avenue for control of the development of type 2 diabetes mellitus and its complications","author":"Liu","year":"2024","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"B43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s41065-025-00385-9","article-title":"Identification of biomarkers and mechanism exploration of ferroptosis related genes regulated by m6A in type 2 diabetes mellitus","volume":"162","author":"Wang","year":"2025","journal-title":"Hereditas"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1166756","article-title":"N6-methyladenosine RNA modification: an emerging molecule in type 2 diabetes metabolism","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12933-025-02942-y","article-title":"Circulating long non-coding RNAs as predictors of type 2 diabetes mellitus development: results from the CORDIOPREV study","volume":"24","author":"Boughanem","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-020-03810-x","article-title":"Upregulation of long non-coding RNA MEG3 in type 2 diabetes mellitus complicated with vascular disease: a case-control study","volume":"473","author":"Chang","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3407","article-title":"Cis-regulation of antisense non-coding RNA at the JAZF1 locus in type 2 diabetes","volume":"24","author":"Ding","year":"2022","journal-title":"J Gene Med"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2174\/1381612828666220428093207","article-title":"NEAT1: a novel long non-coding RNA involved in mediating type 2 diabetes and its various complications","volume":"28","author":"Jia","year":"2022","journal-title":"Curr Pharm Des"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24280","article-title":"Long non-coding RNA screening and identification of potential biomarkers for type 2 diabetes","volume":"36","author":"Ma","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v15.i5.476","article-title":"Exosomes from circ-Astn1-modified adipose-derived mesenchymal stem cells enhance wound healing through miR-138-5p\/SIRT1\/FOXO1 axis regulation","volume":"15","author":"Wang","year":"2023","journal-title":"World J Stem Cells"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8162524","article-title":"High-throughput sequencing and exploration of the lncRNA-circRNA-miRNA-mRNA network in type 2 diabetes mellitus","volume":"2020","author":"Yang","year":"2020","journal-title":"BioMed Res Int"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2025.109042","article-title":"The role of circRNA in insulin resistance and its progression induced by adipose inflammation","volume":"39","author":"Liu","year":"2025","journal-title":"J Diabetes Complications"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1177\/15353702221110648","article-title":"Hsa-miR-607, lncRNA TUG1 and hsa_circ_0071106 can be combined as biomarkers in type 2 diabetes mellitus","volume":"247","author":"Su","year":"2022","journal-title":"Exp Biol Med (Maywood)"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-025-01578-y","article-title":"CircRNA-mediated ceRNA regulatory networks: transcriptomic insights into obesity type 2 diabetes progression and treatment strategies","volume":"17","author":"Zhen","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13396","article-title":"Micro-ribonucleic acid-23a-3p prevents the onset of type 2 diabetes mellitus by suppressing the activation of nucleotide-binding oligomerization-like receptor family pyrin domain containing 3 inflammatory bodies-caused pyroptosis through negatively regulating NIMA-related kinase 7","volume":"12","author":"Chang","year":"2021","journal-title":"J Diabetes Investig"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.522340","article-title":"Overexpression of microRNA-216a-3p accelerates the inflammatory response in cardiomyocytes in type 2 diabetes mellitus by targeting IFN-\u03b12","volume":"11","author":"Liu","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7113","article-title":"Effects of delta-tocotrienol supplementation on glycemic control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: a randomized control trial","volume":"35","author":"Mahjabeen","year":"2021","journal-title":"Phytother Res"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251910723","article-title":"miRNAs as epigenetic biomarkers in the study of the bidirectional relationship between type 2 diabetes mellitus and periodontitis: a systematic review","volume":"25","author":"Mata-Monterde","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12933-019-0918-x","article-title":"Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review","volume":"18","author":"Pordzik","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.917041","article-title":"MiRNA and associated inflammatory changes from baseline to hypoglycemia in type 2 diabetes","volume":"13","author":"Ramanjaneya","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06850-8","article-title":"Circulating expression levels of CircHIPK3 and CDR1as circular-RNAs in type 2 diabetes patients","volume":"49","author":"Rezaeinejad","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-016-0943-0","article-title":"Hsa_circ_0054633 in peripheral blood can be used as a diagnostic biomarker of pre-diabetes and type 2 diabetes mellitus","volume":"54","author":"Zhao","year":"2017","journal-title":"Acta Diabetol"},{"key":"B63","article-title":"Serum hsa_circ_0054633 is elevated and correlated with clinical features in type 2 diabetes mellitus","volume":"51","author":"Liang","year":"2021","journal-title":"Ann Clin Lab Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab101","article-title":"Identification of circulating hsa_circ_0063425 and hsa_circ_0056891 as novel biomarkers for detection of type 2 diabetes","volume":"106","author":"Lu","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.27173","article-title":"The PI3K\/AKT pathway in obesity and type 2 diabetes","volume":"14","author":"Huang","year":"2018","journal-title":"Int J Biol Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/cbin.12189","article-title":"The PI3K\/Akt signaling axis and type 2 diabetes mellitus (T2DM): from mechanistic insights into possible therapeutic targets","volume":"48","author":"Taheri","year":"2024","journal-title":"Cell Biol Int"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118898","article-title":"Network pharmacology analysis revealed the mechanism and active compounds of jiao tai wan in the treatment of type 2 diabetes mellitus via SRC\/PI3K\/AKT signaling","volume":"337","author":"Ye","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1177\/1479164117722714","article-title":"Hsa-circRNA11783\u20132 in peripheral blood is correlated with coronary artery disease and type 2 diabetes mellitus","volume":"14","author":"Li","year":"2017","journal-title":"Diabetes Vasc Dis Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12041-023-01442-w","article-title":"Serum exosomal hsa_circRNA_0001842 is the potential biomarker for diagnosing lower limb vascular disease in type 2 diabetes mellitus","volume":"102","author":"Liu","year":"2023","journal-title":"J Genet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1172\/jci180900","article-title":"Erythrocyte-derived extracellular vesicles induce endothelial dysfunction through arginase-1 and oxidative stress in type 2 diabetes","volume":"135","author":"Collado","year":"2025","journal-title":"J Clin Invest"},{"key":"B71","doi-asserted-by":"publisher","first-page":"C1189","DOI":"10.1152\/ajpcell.00536.2019","article-title":"Extracellular vesicles as signaling mediators in type 2 diabetes mellitus","volume":"318","author":"Noren Hooten","year":"2020","journal-title":"Am J Physiol Cell Physiol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b07643","article-title":"Human mesenchymal stem cell derived exosomes alleviate type 2 diabetes mellitus by reversing peripheral insulin resistance and relieving \u03b2-cell destruction","volume":"12","author":"Sun","year":"2018","journal-title":"ACS Nano"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.cmet.2022.08.004","article-title":"Extracellular vesicles mediate the communication of adipose tissue with brain and promote cognitive impairment associated with insulin resistance","volume":"34","author":"Wang","year":"2022","journal-title":"Cell Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2019.1625677","article-title":"Extracellular vesicles in type 2 diabetes mellitus: key roles in pathogenesis, complications, and therapy","volume":"8","author":"Xiao","year":"2019","journal-title":"J Extracell Vesicles"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14865","article-title":"Research progress of extracellular vesicles in type 2 diabetes and its complications","volume":"39","author":"Zhang","year":"2022","journal-title":"Diabetes Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23856","article-title":"Hsa_circ_0054633 association of C peptide is related to IL-17 and TNF-\u03b1 in patients with diabetes mellitus receiving insulin treatment","volume":"35","author":"Dai","year":"2021","journal-title":"J Clin Lab Anal"},{"key":"B77","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s11658-023-00530-0","article-title":"Increased serum extrachromosomal circular DNA SORBS1(circle) level is associated with insulin resistance in patients with newly diagnosed type 2 diabetes mellitus","volume":"29","author":"Kong","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B78","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.canlet.2018.01.038","article-title":"The interplay between noncoding RNAs and insulin in diabetes","volume":"419","author":"Tian","year":"2018","journal-title":"Cancer Lett"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3390\/toxics12120883","article-title":"Circ_0000284 is involved in arsenite-induced hepatic insulin resistance through blocking the plasma membrane translocation of GLUT4 in hepatocytes via IGF2BP2\/PPAR-\u03b3","volume":"12","author":"Xu","year":"2024","journal-title":"Toxics"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2010.0219","article-title":"GLUT4 gene polymorphisms and their association with type 2 diabetes in south Indians","volume":"13","author":"Bodhini","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2025.03.029","article-title":"Injectable skeletal muscle constructs overexpressing GLUT4 for type 2 diabetes intervention","volume":"197","author":"Shoyhet","year":"2025","journal-title":"Acta Biomater"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202200149rr","article-title":"CircRNA hsa_circ_0071336 is associated with type 2 diabetes through targeting the miR-93-5p\/GLUT4 axis","volume":"36","author":"Yan","year":"2022","journal-title":"FASEB J"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.11968","article-title":"miR-93-5p promotes insulin resistance to regulate type 2 diabetes progression in HepG2 cells by targeting HGF","volume":"23","author":"Zhou","year":"2021","journal-title":"Mol Med Rep"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.s211188","article-title":"Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats","volume":"12","author":"Mi","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.14.3858","article-title":"PED\/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus","volume":"17","author":"Condorelli","year":"1998","journal-title":"EMBO J"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.1.25","article-title":"Role of glucose transport and GLUT4 transporter protein in type 2 diabetes mellitus","volume":"77","author":"Davidson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.13703\/j.0255-2930.20230129-k0001","article-title":"Effects of electroacupuncture on the glucose-lipid metabolism and the expression of ZAG and GLUT4 in the femoral quadriceps and adipose tissue in the rats with type 2 diabetes mellitus","volume":"43","author":"Guo","year":"2023","journal-title":"Zhongguo Zhen Jiu"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.0c00645","article-title":"Liver phosphoenolpyruvate carboxykinase-1 downregulation via siRNA-functionalized graphene oxide nanosheets restores glucose homeostasis in a type 2 diabetes mellitus in vivo model","volume":"32","author":"Singh","year":"2021","journal-title":"Bioconjug Chem"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1042\/bst20221066","article-title":"Insulin signalling and GLUT4 trafficking in insulin resistance","volume":"51","author":"van Gerwen","year":"2023","journal-title":"Biochem Soc Trans"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4128315","article-title":"Identification of circular RNAs regulating islet \u03b2-cell autophagy in type 2 diabetes mellitus","volume":"2019","author":"Bai","year":"2019","journal-title":"BioMed Res Int"},{"key":"B91","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s10020-024-00991-9","article-title":"Mbnl1-mediated alternative splicing of circMlxipl regulates Rbbp6-involved ChREBP turnover to inhibit lipotoxicity-induced \u03b2-cell damage","volume":"30","author":"Gong","year":"2024","journal-title":"Mol Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.2022076","article-title":"Circular RNA PIP5K1A act as microRNA-552-3p sponge to regulates inflammation, oxidative damage in glucolipotoxicity-induced pancreatic INS-1 \u03b2-cells via Janus kinase 1","volume":"13","author":"Ren","year":"2022","journal-title":"Bioengineered"},{"key":"B93","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.molmet.2018.01.010","article-title":"Circular RNAs as novel regulators of \u03b2-cell functions in normal and disease conditions","volume":"9","author":"Stoll","year":"2018","journal-title":"Mol Metab"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108837","article-title":"Hsa_circ_0054633 mediates apoptosis and insulin secretion in human pancreatic \u03b2 cells through miR-409-3p\/caspase-8 axis","volume":"176","author":"Sun","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B95","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12920-020-0713-2","article-title":"Islet-expressed circular RNAs are associated with type 2 diabetes status in human primary islets and in peripheral blood","volume":"13","author":"Haque","year":"2020","journal-title":"BMC Med Genomics"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24583","article-title":"hsa_circ_0115355 promotes pancreatic \u03b2-cell function in patients with type 2 diabetes through the miR-145\/SIRT1 axis","volume":"36","author":"Dai","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.2741\/3428","article-title":"Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes","volume":"14","author":"Imai","year":"2009","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1093\/stcltm\/szae038","article-title":"Mesenchymal stromal cells ameliorate mitochondrial dysfunction in \u03b1 cells and hyperglucagonemia in type 2 diabetes via SIRT1\/FoxO3a signaling","volume":"13","author":"Song","year":"2024","journal-title":"Stem Cells Transl Med"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvae100","article-title":"Inhibition of de novo ceramide synthesis by sirtuin-1 improves beta-cell function and glucose metabolism in type 2 diabetes","volume":"120","author":"Velagapudi","year":"2024","journal-title":"Cardiovasc Res"},{"key":"B100","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13098-022-00852-7","article-title":"Targeting ferroptosis with miR-144-3p to attenuate pancreatic \u03b2 cells dysfunction via regulating USP22\/SIRT1 in type 2 diabetes","volume":"14","author":"Zhang","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"B101","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1900\/rds.2016.13.17","article-title":"Understanding genetic heterogeneity in type 2 diabetes by delineating physiological phenotypes: SIRT1 and its gene network in impaired insulin secretion","volume":"13","author":"Ali","year":"2016","journal-title":"Rev Diabetes Stud"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1231970","DOI":"10.1155\/2022\/1231970","article-title":"\u2206nFGF1 protects \u03b2-cells against high glucose-induced apoptosis via the AMPK\/SIRT1\/PGC-1\u03b1 axis","volume":"2022","author":"Chen","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B103","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/13813455.2021.1956976","article-title":"SIRT1: a promising therapeutic target in type 2 diabetes mellitus","volume":"130","author":"Mihanfar","year":"2024","journal-title":"Arch Physiol Biochem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0355-7","article-title":"Pancreatic \u03b2-cells in type 1 and type 2 diabetes mellitus: different pathways to failure","volume":"16","author":"Eizirik","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1172\/jci129188","article-title":"\u03b2 cell dysfunction during progression of metabolic syndrome to type 2 diabetes","volume":"129","author":"Hudish","year":"2019","journal-title":"J Clin Invest"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/703538","article-title":"Mitochondrial dysfunction and \u03b2-cell failure in type 2 diabetes mellitus","volume":"2012","author":"Ma","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2020.1771047","article-title":"Beta-cell failure in type 2 diabetes: mechanisms, markers, and clinical implications","volume":"132","author":"Wysham","year":"2020","journal-title":"Postgrad Med"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239005","article-title":"Cardiac autonomic neuropathy: a progressive consequence of chronic low-grade inflammation in type 2 diabetes and related metabolic disorders","volume":"21","author":"Bakkar","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/27697061.2024.2352401","article-title":"Additive interaction between insulin resistance, chronic low-grade inflammation and vitamin D deficiency on the risk of type 2 diabetes mellitus: a cohort study","volume":"43","author":"Bennouar","year":"2024","journal-title":"J Am Nutr Assoc"},{"key":"B110","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12902-024-01671-9","article-title":"The mediating role of chronic low-grade inflammation participation in the relationship between obesity and type 2 diabetes: findings from the NHANES","volume":"24","author":"Li","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746151","article-title":"Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: the importance of metabolites","volume":"12","author":"Russo","year":"2021","journal-title":"Front Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.2174\/1568026615666150827094815","article-title":"Organoselenium small molecules and chromium(III) complexes for intervention in chronic low-grade inflammation and type 2 diabetes","volume":"16","author":"Zhou","year":"2016","journal-title":"Curr Top Med Chem"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1177\/1479164118817942","article-title":"Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease","volume":"16","author":"Rattik","year":"2019","journal-title":"Diabetes Vasc Dis Res"},{"key":"B114","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41574-021-00575-1","article-title":"Adaptive immune cells shape obesity-associated type 2 diabetes mellitus and less prominent comorbidities","volume":"18","author":"SantaCruz-Calvo","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114434","article-title":"CB2 stimulation of adipose resident ILC2s orchestrates immune balance and ameliorates type 2 diabetes mellitus","volume":"43","author":"Shafiei-Jahani","year":"2024","journal-title":"Cell Rep"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/3759339","article-title":"Exosomes as emerging regulators of immune responses in type 2 diabetes mellitus","volume":"2024","author":"Zheng","year":"2024","journal-title":"J Diabetes Res"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202510.0427.v1","article-title":"Non-coding RNA in type 2 diabetes cardio-renal complications and SGLT2 inhibitor response","volume":"26","author":"Rykova","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12186022","article-title":"From innate immunity to metabolic disorder: a review of the NLRP3 inflammasome in diabetes mellitus","volume":"12","author":"Ni\u021bulescu","year":"2023","journal-title":"J Clin Med"},{"key":"B119","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00011-021-01467-w","article-title":"Silencing circANKRD36 inhibits streptozotocin-induced insulin resistance and inflammation in diabetic rats by targeting miR-145 via XBP1","volume":"70","author":"Lu","year":"2021","journal-title":"Inflammation Research: Off J Eur Histamine Res Soc [et al]"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3783","article-title":"Screening of circular RNAs and validation of circANKRD36 associated with inflammation in patients with type 2 diabetes mellitus","volume":"42","author":"Fang","year":"2018","journal-title":"Int J Mol Med"},{"key":"B121","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s10194-025-02090-4","article-title":"Identification of comorbid genes between type 2 diabetes and migraine through peripheral blood single-cell and Mendelian randomization analysis","volume":"26","author":"Yuan","year":"2025","journal-title":"J Headache Pain"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1285509","article-title":"Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"key":"B123","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/iwj.13597","article-title":"Pyridoxamine ameliorates methylglyoxal-induced macrophage dysfunction to facilitate tissue repair in diabetic wounds","volume":"19","author":"Jiang","year":"2022","journal-title":"Int Wound J"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00537","article-title":"Differential expression of human peripheral mononuclear cells phenotype markers in type 2 diabetic patients and type 2 diabetic patients on metformin","volume":"9","author":"Al Dubayee","year":"2018","journal-title":"Front Endocrinol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/cvr\/cvae079","article-title":"NLRP3 inflammasome-mediated premature immunosenescence drives diabetic vascular aging dependent on the induction of perivascular adipose tissue dysfunction","volume":"121","author":"Tai","year":"2025","journal-title":"Cardiovasc Res"},{"key":"B126","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: a sensor for metabolic danger","volume":"327","author":"Schroder","year":"2010","journal-title":"Sci (New York NY)"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14134606","article-title":"The role of NLRP3 inflammasome in type 2 diabetes mellitus and its macrovascular complications","volume":"14","author":"Karamitsos","year":"2025","journal-title":"J Clin Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.828240","article-title":"Circ_0004951 promotes pyroptosis of renal tubular cells via the NLRP3 inflammasome in diabetic kidney disease","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"B129","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41392-022-01306-2","article-title":"CircRNA DICAR as a novel endogenous regulator for diabetic cardiomyopathy and diabetic pyroptosis of cardiomyocytes","volume":"8","author":"Yuan","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1111\/febs.16105","article-title":"The role of T-cell immunity in COVID-19 severity amongst people living with type II diabetes","volume":"288","author":"Tong","year":"2021","journal-title":"FEBS J"},{"key":"B131","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/dmrr.2720","article-title":"T-cell receptor repertoire variation may be associated with type 2 diabetes mellitus in humans","volume":"32","author":"Frankl","year":"2016","journal-title":"Diabetes\/Metabolism Res Rev"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-071934","article-title":"Associations between human cytomegalovirus infection and type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"B133","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduction Targeted Ther"},{"key":"B134","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41577-021-00557-4","article-title":"The role of T cells in age-related diseases","volume":"22","author":"Carrasco","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1111\/imr.13206","article-title":"Senescent T cells: beneficial and detrimental roles","volume":"316","author":"Laphanuwat","year":"2023","journal-title":"Immunol Rev"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-024-09863-4","article-title":"Linarin ameliorates restenosis after vascular injury in type 2 diabetes mellitus via regulating ADAM10-mediated Notch signaling pathway","volume":"24","author":"Jiang","year":"2024","journal-title":"Cardiovasc Toxicol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13206","article-title":"Is neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus","volume":"50","author":"Kocak","year":"2020","journal-title":"Eur J Clin Invest"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2022.76.135-139","article-title":"The effect of hypoxia inducible factor -1 alpha and vascular endothelial growth factor level in type 2 diabetes microvascular complications and development","volume":"76","author":"Rusdiana","year":"2022","journal-title":"Med Arch"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.7554\/elife.97267.3","article-title":"Circular RNA HMGCS1 sponges MIR4521 to aggravate type 2 diabetes-induced vascular endothelial dysfunction","volume":"13","author":"Zhang","year":"2024","journal-title":"Elife"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1111\/dme.14968","article-title":"UCMSCs-derived exosomal circHIPK3 promotes ulcer wound angiogenesis of diabetes mellitus via miR-20b-5p\/Nrf2\/VEGFA axis","volume":"40","author":"Liang","year":"2023","journal-title":"Diabetes Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1093\/pcmedi\/pbae021","article-title":"Exosomal miRNAs and isomiRs: potential biomarkers for type 2 diabetes mellitus","volume":"7","author":"Sou","year":"2024","journal-title":"Precis Clin Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1007\/s12033-023-00954-1","article-title":"Circular RNA PIP5K1A promotes glucose and lipid metabolism disorders and inflammation in type 2 diabetes mellitus","volume":"66","author":"Song","year":"2024","journal-title":"Mol Biotechnol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.19852\/j.cnki.jtcm.2025.06.005","article-title":"Electroacupuncture alleviates type 2 diabetes mellitus by promoting plasma-derived exosomal circular RNA of enhancer of zeste homolog 1 expression","volume":"45","author":"Yin","year":"2025","journal-title":"J Tradit Chin Med"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.70149","article-title":"Circular RNAs as biomarkers and therapeutic targets in diabetic cardiovascular complications","volume":"9","author":"Beniwal","year":"2026","journal-title":"Endocrinology Diabetes Metab"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1541261","article-title":"Differential expression and correlation analysis of whole transcriptome for type 2 diabetes mellitus","volume":"16","author":"Liu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155332","article-title":"Pharmacotherapy of type 2 diabetes: an update and future directions","volume":"137","author":"DeMarsilis","year":"2022","journal-title":"Metabolism"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.17.633590","article-title":"Single-cell decoding of human islet cell type-specific alterations in type 2 diabetes reveals converging genetic- and state-driven \u03b2-cell gene expression defects","author":"Bandesh","year":"2025","journal-title":"bioRxiv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1815722\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:26:47Z","timestamp":1778819207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1815722\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":147,"alternative-id":["10.3389\/fimmu.2026.1815722"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1815722","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1815722"}}